US wants COVID vaccine patent waiver to benefit world, not boost China biotech By Reuters – Investing.com

US wants COVID vaccine patent waiver to benefit world, not boost China biotech By Reuters – Investing.com

By Andrea Shalal, Carl O'Donnell and David Lawder

(Reuters) - The Biden administration is examining ways to ensure that a waiver of COVID-19 vaccine patents to aid poor countries will not hand sensitive U.S. biopharmaceutical technology to China and Russia, responding to a chorus of concerns, U.S. and industry officials say.

President Joe Biden on Wednesday backed the U.S. entering negotiations at the World Trade Organization for the waiver of intellectual property rights as a means to boost vaccine supplies by allowing poorer countries to make their own.